BCL2 and cancer: TAS-115 markedly inhibited cancer cell proliferation, as shown by reduced GFP+ MDA-MB-231 cell populations, and induced apoptosis via upregulation of Bax and Caspase-3, alongside suppression of Bcl-2 expression.